401. The percutaneous endoscopic gastrostomy care practices of patients and the care burden of caregivers: a cross-sectional study.
作者: Erhan Ergin.;Yasemin Altınbaş.;Türkan Karaca.;Emine Derya İster.
来源: BMC Gastroenterol. 2026年26卷1期74页
This study aims to evaluate the care practices of adult patients with percutaneous endoscopic gastrostomy and the care burden of individuals who provide care for these patients in this regard.
402. Association of the C-reactive protein-triglyceride-glucose index with liver disease risk: findings from a nationwide Chinese cohort.
作者: Jinpeng Zheng.;Dongwei Xie.;Yuanyuan Nong.;Kui Jia.;Dingran Sha.
来源: BMC Gastroenterol. 2026年26卷1期87页
Both insulin resistance and low-grade inflammation contribute to liver disease development, yet their combined predictive role remains unclear at the population level.
403. HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients.
作者: Yandi Xie.;Xiaojing Zhang.;Xiaozhou Yang.;Sujun Zheng.;Shuyun Zhang.;Xiaoying Zhang.;Haiyan Kang.;Xuefei Duan.;Wenpin Cai.;Peng Yin.;Xinghuan Ma.;Juan Liu.;Fengmin Lu.;Lizhong Dai.;Bo Feng.
来源: BMC Gastroenterol. 2026年26卷1期76页
This multicenter study evaluated serum HBV RNA as a prognostic biomarker for nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB), focusing on correlations with HBV DNA/HBsAg and predictive value for virological response (VR) and HBeAg seroconversion.
404. Analysis of the incidence and risk factors of colorectal polyps in patients with chronic hepatitis B complicated by non - alcoholic fatty liver disease.
作者: Lin Ma.;Wen-Wen Zheng.;Yan Zhang.;Wei Wei.;Ying Zhao.;Xiao-Jiang Zhang.;Peng-Yu Pan.;Jian-Zhou Li.;Zhan-Hong Li.;Qing-Ping Wang.;Chun-Yan Wang.
来源: BMC Gastroenterol. 2026年26卷1期77页
To investigate the incidence of colorectal polyps in patients with chronic hepatitis B (CHB) complicated by non - alcoholic fatty liver disease (NAFLD) and its risk factors.
405. I-FABP, citrulline and non-invasive liver dysfunction indices in patients with depression - cross-sectional study results.
作者: Jakub Rogalski.;Joanna Grzelczyk.;Aleksandra Margulska.;Grzegorz Mirocha.;Grażyna Budryn.;Dominik Strzelecki.;Oliwia Gawlik-Kotelnicka.
来源: BMC Gastroenterol. 2026年26卷1期88页
Dysfunction of the intestinal epithelial barrier, often observed in individuals with depression and Metabolic Syndrome (MetS), may contribute to liver dysfunction and increased cardiovascular risk (CVR). However, hepatic alterations influenced by enteric dysfunction in individuals with depression remain insufficiently investigated. The aim of the study is to investigate the associations between the non-invasive indices of hepatic steatosis and fibrosis and intestinal dysfunction biomarkers in patients with depressive disorders, taking into account the presence of MetS or its components, as well as dietary, behavioral and psychosocial factors, and antidepressant intake status.
406. Predictors of 1-month and 3-month readmission among patients with decompensated advanced chronic liver disease admitted at a tertiary hospital in Tanzania: a hospital-based prospective cohort study.
Sub-Saharan African countries remain adversely affected by the burden of liver cirrhosis, recording the highest age-standardized death rates in the world. Hospital admission represents a measurable proxy of the burden of cirrhosis, driving up healthcare costs and imposing a burden on patients and caretakers. This study was set out to fill a local gap in knowledge of the rate and predictors of readmission among patients with decompensated cirrhosis which is crucial in order to reduce it.
407. Therapeutic potential of β-sitosterol in methotrexate-induced liver injury: association with STING and ERK-1 pathways.
作者: Mehmet Ulusan.;Mustafa Yildiz.;Mumin Alper Erdogan.;Ozkan Simsek.;Bertug Bekir Ciftci.;Mesih Kocamuftuoglu.;Oytun Erbas.
来源: BMC Gastroenterol. 2026年26卷1期75页
Methotrexate (MTX) is a commonly used drug to treat various cancers and autoimmune disorders, but its clinical utility is often limited by hepatotoxicity. β-sitosterol is a bioactive phytosterol compound that is naturally present in various plant foods and exhibits multiple antioxidant, anticancer and immunomodulatory activities. It has not been fully explored for its potential protective effects against liver injury. This study investigated whether β-sitosterol is associated with reduced hepatic injury in a short-term MTX model.
412. HMGB1-enhanced autophagic degradation of E-cadherin facilitates mesothelial trans-differentiation and postoperative peritoneal adhesion.
作者: Xuetao Yuan.;Shuting Yang.;Chao Qu.;Rui Zhang.;Yaru Ren.;Yanjun Sun.;Enmeng Li.;Gan Li.;Junxiang Zhang.;Jiayin Du.;Tianli Shen.;Zhengdong Jiang.;Xuqi Li.
来源: BMC Gastroenterol. 2025年26卷1期83页
Postoperative peritoneal adhesion (PA), a prevalent complication of abdominal surgery, arises from aberrant healing of the injured peritoneum. This process involves mesothelial cell trans-differentiation into myofibroblast-like cells, driving peritoneal matrix remodeling and pathological fibrous band formation between organs. Existing therapeutic strategies to prevent PA exhibit limited efficacy, underscoring the need for previously unrecognized mechanistic insights into PA pathogenesis. Here, we elucidate the role of autophagy in mesothelial cell transition and PA development. Utilizing a murine PA model coupled with comprehensive in vitro analyses, we demonstrate that HMGB1-mediated autophagy facilitates TGF-β mediated mesothelial cell trans-differentiation. Specifically, autophagic degradation of E-cadherin counteracts TGF-β-driven mesothelial transition. Pharmacological activation of autophagy via rapamycin or recombinant HMGB1 potentiated this transition, whereas HMGB1 inhibitor (glycyrrhizin) or autophagy suppressor (spautin-1) markedly attenuated it. Crucially, early postoperative administration of glycyrrhizin or spautin-1 significantly reduced PA severity. Our findings unveil autophagy and HMGB1 as pivotal regulator targets of mesothelial plasticity during PA formation, provide mechanistic insights into peritoneum repair, and propose novel therapeutic avenues for PA prevention.
413. Integrated structural and functional brain imaging reveals biomarkers of disease activity in Crohn's disease.
作者: Chunhui Bao.;Shuai Xu.;Luyi Wu.;Xinyi Zhu.;Di Wang.;Zhenjie Zhang.;Changcheng Qu.;Yin Shi.;Xiaoqing Zeng.;Jie Zhong.;Jianye Zhang.;Song Wang.;Rencheng Zheng.;Xiaoming Jin.;He Wang.;Huirong Liu.;Huangan Wu.
来源: BMC Gastroenterol. 2025年26卷1期85页
The brain’s response to intestinal inflammation in Crohn’s disease (CD) remains poorly characterized. We aimed to identify a neuroimaging signature of disease activity by integrating structural and functional brain metrics with machine learning.
414. mRNA expression of NLRP3 and IL1B in inflammatory bowel diseases: a systematic review and meta-analysis.
作者: Paula I Metselaar.;Roos C H Schilder.;Aletta D Kraneveld.;Anje A Te Velde.;Andrew Y F Li Yim.
来源: BMC Gastroenterol. 2025年26卷1期86页
Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the gastrointestinal tract. Clinical studies of IBD robustly show elevated interleukin 1β (IL-1β) levels in intestinal tissue, implicating the NLR family pyrin domain containing 3 (NLRP3) inflammasome, which controls IL-1β secretion in myeloid cells. In this study, we aimed to ground potential NLRP3 involvement in IBD in molecular evidence from human studies.
415. Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer.
作者: Jinyue Liu.;Yueping Jiang.;Yueyi Xing.;Shijin Wang.;Beibei Ma.;Mengdi Guo.;Xue Jing.;Libin Liu.
来源: BMC Gastroenterol. 2025年26卷1期81页
This study aimed to assess the prognostic significance of serum lipoprotein(a) [Lp(a)] levels regarding overall survival (OS) and progression-free survival (PFS) among patients diagnosed with pancreatic cancer (PC).
416. Sodium butyrate entrapped chitosan-PAMAM for suppression of colorectal cancer cells.
作者: Ruaa Mahdi Mayih Al-Zihaymee.;Javad Mohammadnejad.;Asghar Narmani.;Hanieh Jafar.;Gülüzar Özbolat.;Amin Daemi.;Yusuf Döğüş.;Seyyedeh Touran Hosseini.
来源: BMC Gastroenterol. 2025年25卷1期875页
Cancer treatment is a major concern of health worldwide. Nowadays, colorectal cancer is one of the most prevalent diseases throughout the globe. Therefore, novel cancer treatment modalities are required to stop cancer. Thus, this paper aims to develop a novel drug delivery system (DDS) based on Chitosan (CS), polyamidoamine (PAMAM G4), and Nanoparticles (NP) for efficient delivery of sodium butyrate (NB) and Fe2O3 to SW480 colorectal cancer cells.
417. Prevalence of gallstone disease and its association with altitude and ethnicity among employee health check-upers in the Qinghai-Tibet Plateau.
作者: Shenggui Qi.;Li Li.;Yuhua Yan.; Gengdeng.;Xiaofeng Ma.;Airong Yang.;Hongguang Fan.
来源: BMC Gastroenterol. 2025年25卷1期873页
This study aimed to investigate the prevalence of gallstone disease among health check-upers (employees) in the Qinghai-Tibet Plateau and clarify the independent effects of altitude, ethnicity, and their interaction on gallstone disease risk, so as to provide evidence for precise prevention and control of gallstone disease in high-altitude multi-ethnic regions.
418. Evaluating quality indicators in colorectal cancer screening via fecal immunochemical tests: a five-year study from a developing country.
作者: Elham Tabesh.;Farimah Rahimi.;Maryam Soheilipour.;Neda Tavakoli-Moghadam.;Zahra Ravankhah.;Seyedeh-Zeynab Hosseinian.;Peyman Adibi.
来源: BMC Gastroenterol. 2025年26卷1期82页
Assessing quality indicators in colorectal cancer (CRC) screening via the fecal immunochemical test (FIT) is crucial. However, data on developing countries with lower CRC rates, lifestyle transitions, newly established screening programs, and no consensus on optimal targets are scarce.
419. Morphine use and clinical outcomes in acute pancreatitis: a tertiary-center retrospective cohort study.
作者: Abdulrahman Ibn Awadh.;Renad Meshal Alharbi.;Mohannad Abuobaid.;Musthafa Chalikandy Peedikayil.
来源: BMC Gastroenterol. 2025年25卷1期871页
The safety of morphine in acute pancreatitis (AP) remains controversial due to theoretical risks of exacerbating complications. This study evaluated whether early morphine use correlates with clinical deterioration in AP.
420. Prognostic factors and survival outcomes in colorectal cancer: insights from a Ghanaian cohort.
作者: Tonnies Abeku Buckman.;Samuel Asamoah Sakyi.;Joseph Yorke.;Jonathan Laryea.;Bolni Marius Nagalo.;Michael Nyantakyi.;Emmanuella Nsenbah Batu.;Ebenezer Senu.;Ernest Osei-Bonsu.;Daniel Sam.;Emelia Osei Boakye.;Francis Acheampong.;Francis Agyemang-Yeboah.;Christian Obirikorang.;Emmanuel Acheampong.
来源: BMC Gastroenterol. 2025年25卷1期876页
Colorectal cancer (CRC) incidence in Ghana has increased significantly in recent years. Despite medical advances, survival rates remain low, with challenges in CRC screening implementation contributing to late-stage diagnoses and poor outcomes.
|